These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1932528)

  • 1. Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): levels in the normal population and relation to cholesterol.
    Sandset PM; Larsen ML; Abildgaard U; Lindahl AK; Odegaard OR
    Blood Coagul Fibrinolysis; 1991 Jun; 2(3):425-33. PubMed ID: 1932528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered recombinant factor VII Q217 variants with altered inhibitor specificities.
    Chang YJ; Hamaguchi N; Chang SC; Ruf W; Shen MC; Lin SW
    Biochemistry; 1999 Aug; 38(34):10940-8. PubMed ID: 10460149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional properties of factor VIIa/tissue factor formed with purified tissue factor and with tissue factor expressed on cultured endothelial cells.
    Almus FE; Rao LV; Rapaport SI
    Thromb Haemost; 1989 Dec; 62(4):1067-73. PubMed ID: 2617454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of the factor Xa-dependent inhibitor of factor VIIa/tissue factor (extrinsic pathway inhibitor) from cell supernates of cultured human umbilical vein endothelial cells.
    Warn-Cramer BJ; Almus FE; Rapaport SI
    Thromb Haemost; 1989 Feb; 61(1):101-5. PubMed ID: 2665164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibitor of F VIIa in plasma measured with a sensitive chromogenic substrate assay: comparison with antithrombin, protein C and heparin cofactor II in a clinical material.
    Abildgaard U; Sandset PM; Andersson TR; Odegaard OR; Rosĕn S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):274-7. PubMed ID: 2465215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma.
    Nordfang O; Valentin S; Beck TC; Hedner U
    Thromb Haemost; 1991 Oct; 66(4):464-7. PubMed ID: 1796397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical exercise enhances plasma levels of extrinsic pathway inhibitor (EPI).
    Hansen JB; Olsen JO; Osterud B
    Thromb Haemost; 1990 Aug; 64(1):124-6. PubMed ID: 2274917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sensitive, accurate assay for extrinsic pathway inhibitor (EPI) activity in rabbit plasma: paradoxical effect of excess exogenous factor X.
    Warr TA; Rao LV; Rapaport SI
    Thromb Res; 1990 Aug; 59(4):773-82. PubMed ID: 2080494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lipoprotein-associated coagulation inhibitor.
    Broze GJ; Girard TJ; Novotny WF
    Prog Hemost Thromb; 1991; 10():243-68. PubMed ID: 2008533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new sensitive chromogenic substrate assay of tissue factor pathway inhibitor type 1.
    Bendz B; Andersen TO; Sandset PM
    Thromb Res; 2000 Mar; 97(6):463-72. PubMed ID: 10704656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifications of extrinsic pathway inhibitor (EPI) and factor Xa that affect their ability to interact and to inhibit factor VIIa/tissue factor: evidence for a two-step model of inhibition.
    Warn-Cramer BJ; Rao LV; Maki SL; Rapaport SI
    Thromb Haemost; 1988 Dec; 60(3):453-6. PubMed ID: 3238648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein associated coagulation inhibitor, factor VII, antithrombin III, and monocyte tissue factor following surgery.
    Carson SD; Haire WD; Broze GJ; Novotny WF; Pirrucello SJ; Duggan MJ
    Thromb Haemost; 1991 Nov; 66(5):534-9. PubMed ID: 1803617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.
    Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W
    Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrinsic pathway inhibitor (EPI) released to the blood by heparin is a more powerful coagulation inhibitor than is recombinant EPI.
    Lindahl AK; Abildgaard U; Larsen ML; Staalesen R; Hammer AK; Sandset PM; Nordfang O; Beck TC
    Thromb Res; 1991 Jun; 62(6):607-14. PubMed ID: 1926055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.
    Pedersen AH; Nordfang O; Norris F; Wiberg FC; Christensen PM; Moeller KB; Meidahl-Pedersen J; Beck TC; Norris K; Hedner U
    J Biol Chem; 1990 Oct; 265(28):16786-93. PubMed ID: 2211593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High plasma levels of extrinsic pathway inhibitor and low levels of other coagulation inhibitors in advanced cancer.
    Lindahl AK; Sandset PM; Abildgaard U; Andersson TR; Harbitz TB
    Acta Chir Scand; 1989 Aug; 155(8):389-93. PubMed ID: 2596246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that plasma lipoproteins inhibit the factor VIIa-tissue factor complex by a different mechanism that extrinsic pathway inhibitor.
    Kondo S; Kisiel W
    Blood; 1987 Dec; 70(6):1947-54. PubMed ID: 3315045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrinsic pathway inhibitor in elective surgery: a comparison with other coagulation inhibitors.
    Sandset PM; Høgevold HE; Lyberg T; Andersson TR; Abildgaard U
    Thromb Haemost; 1989 Nov; 62(3):856-60. PubMed ID: 2595660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrinsic pathway inhibitor--the key to feedback control of blood coagulation initiated by tissue thromboplastin.
    Sandset PM; Abildgaard U
    Haemostasis; 1991; 21(4):219-39. PubMed ID: 1794748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.